Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Equity (2022 - 2025)

bioAffinity Technologies (BIAF) has disclosed Return on Equity for 4 consecutive years, with 1.84% as the latest value for Q4 2025.

  • Quarterly Return on Equity rose 132.0% to 1.84% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.84% through Dec 2025, up 132.0% year-over-year, with the annual reading at 3.02% for FY2025, 59.0% down from the prior year.
  • Return on Equity for Q4 2025 was 1.84% at bioAffinity Technologies, up from 4.36% in the prior quarter.
  • The five-year high for Return on Equity was 33.55% in Q2 2025, with the low at 4.82% in Q1 2025.
  • Average Return on Equity over 4 years is 0.63%, with a median of 1.65% recorded in 2024.
  • Peak annual rise in Return on Equity hit 3557bps in 2025, while the deepest fall reached -316bps in 2025.
  • Over 4 years, Return on Equity stood at 0.69% in 2022, then plummeted by -94bps to 1.34% in 2023, then crashed by -136bps to 3.16% in 2024, then soared by 42bps to 1.84% in 2025.
  • According to Business Quant data, Return on Equity over the past three periods came in at 1.84%, 4.36%, and 33.55% for Q4 2025, Q3 2025, and Q2 2025 respectively.